Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter (O) May 4, 2017

Crystal structure of 3-(4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one, C17H16O2

  • Yavuz Köysal EMAIL logo , Hakan Bülbül , Funda Özdemir , İlhan Özer İlhan and Necmi Dege

Abstract

C17H16O2, monoclinic, P21/c (no. 14), a = 11.6963(12) Å, b = 11.1187(8) Å, c = 11.6902(10) Å, β = 115.545(7)°, V = 1371.7(2) Å3, Z = 4, Rgt(F) = 0.0350, wRref(F2) = 0.0865, T = 293 K.

CCDC no.:: 1515321

The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless prism
Size:0.36 × 0.27 × 0.12 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.8 cm−1
Diffractometer, scan mode:STOE IPDS 2, ω scans
2θmax, completeness:52°, 98.8%
N(hkl)measured, N(hkl)unique, Rint:7194, 2661, 0.037
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 1375
N(param)refined:236
Programs:Stoe programs [1], SHELX [2, 3] , ORTEP [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C10.36180(15)0.32004(16)0.61559(16)0.0787(4)
C20.43587(15)0.27272(15)0.73366(16)0.0788(4)
C30.41923(13)0.15512(14)0.75852(14)0.0729(4)
C40.32929(16)0.08557(15)0.66461(16)0.0814(5)
C50.25615(15)0.13408(14)0.54835(16)0.0749(4)
C60.27015(13)0.25269(13)0.52017(13)0.0660(4)
C70.19122(15)0.30866(15)0.39781(15)0.0740(4)
C80.10143(15)0.25798(15)0.29722(15)0.0734(4)
C90.02624(13)0.32677(13)0.18103(13)0.0704(4)
C10−0.05096(13)0.26101(12)0.06163(13)0.0662(4)
C11−0.10413(15)0.32522(16)−0.05156(16)0.0763(4)
C12−0.17460(16)0.26820(16)−0.16466(16)0.0798(5)
C13−0.19631(13)0.14563(15)−0.17099(14)0.0730(4)
C14−0.14285(15)0.08265(16)−0.05865(16)0.0779(4)
C15−0.07184(14)0.13783(13)0.05549(17)0.0746(4)
C16−0.2733(2)0.0836(2)−0.2941(2)0.0986(6)
C170.5723(2)0.1671(2)0.9754(2)0.0991(6)
O10.48553(10)0.09799(10)0.87164(10)0.0952(4)
O20.02810(11)0.43693(9)0.18209(9)0.0926(4)
H10.3737(14)0.4032(15)0.5996(13)0.093(5)*
H20.4969(14)0.3226(13)0.7989(14)0.091(5)*
H40.3196(15)0.0037(15)0.6841(14)0.104(5)*
H50.1935(13)0.0848(12)0.4841(13)0.081(4)*
H70.2070(13)0.3943(13)0.3907(12)0.085(4)*
H80.0821(13)0.1756(14)0.2962(12)0.082(4)*
H11−0.0863(14)0.4102(15)−0.0479(14)0.097(5)*
H12−0.2063(13)0.3136(13)−0.2413(14)0.085(5)*
H14−0.1552(13)−0.0036(14)−0.0611(13)0.092(5)*
H15−0.0377(13)0.0903(13)0.1305(13)0.081(4)*
H17A0.6045(19)0.1107(18)1.048(2)0.143(8)*
H17B0.6404(18)0.2026(17)0.9546(16)0.129(7)*
H17C0.5260(16)0.2375(17)0.9895(14)0.113(6)*
H18A−0.362(2)0.100(2)−0.325(2)0.173(10)*
H18B−0.267(2)−0.001(2)−0.290(2)0.159(9)*
H18C−0.251(2)0.1087(19)−0.361(2)0.159(9)*

Source of material

Equimolar quanities of p-methylacetophenone (0.01 mol) and p-methoxybenzaldehyde (0.01 mol) were dissolved in ethanol (10 mL) under stirring and aq. NaOH (30%) was added dropwise. The reaction mixture was stirred at room temperature for a few hours. The reaction mixture was diluted with water & acidifed with HCl. The separated solid was filtered and recrystallised from ethanol [5].

IR (ATR) cm−1: 2932 (aromatic—CH), 2837 (aliphatic—CH), 1651 (C = O), 1593–1416 (C = C); 1H-NMR (δ): 8.00–6.94 (−CH), 2.41 (−CH3), 3.91 (−OCH3); 13C-NMR (δ): 21.54 (−CH3), 55.51 (−OCH3), 188 (C = O), 163 (HC = CH), 144–120 (aromatic—CH3), 113.81–113.75 (aliphatic—CH). Anal. Calcd. for C17H16O2: C, 80.95; H, 6.34; Found: C, 80.63; H, 6.07.

Experimental details

The structure was solved by direct methods and refined by full-matrix least-square techniques. All the H atoms in the molecular structure were found and located in difference Fourier map and refined freely. H bond lengths vary between 0.952(14) Å and 0.969(15) Å for aromatic rings.

Comment

Chalcones consist of two aromatic rings which are linked by three carbon atoms with a α,β-unsaturated carbonyl system. Chalcones and their derivatives are interesting materials for their biological activities such as anti-viral, anti-malarial, anti-cancer, antioxidant, anti-inflammatory, antifungal, antileishmanial, anti-tubercular, anti-hyperglycemic properties [6], [7], [8], [9], [10], [11]. They are also used in different applications such as agriculture [12], cosmetics and manufacture of pesticides [13].

The title compund, C17H16O2, shows E conformation with respect to the C = C double bond (C7 = C8 = 1.318(2) Å). In the molecular structure, the methoxy substituted phenyl ring and the methyl substituted phenyl ring are inclined by 13.78(6)°. The maximum deviations within the ring systems are 0.0052(2) Å for C4 atom of the C1—C6 ring and 0.0033(2) Å for atom C12 of the C10—C15 ring. The attached methyl group is co-planar with the related aromatic ring system (C10—C15). The methoxy group is slightly twisted with the C4—C3—O1—C17 and C2—C3—O1—C17 torsion angles of −174.97(16)° and 5.0(2)°, respectively. In the molecular structure, the bond lengths and angles are consistent with the related structures [14, 15] . The crystal structure presents at least one very weak intermolecular hydrogen bond, namely C11—H11⋯O2′ (with symmetry code: −x, −y + 1, −z).

Acknowledgement

The related single crystal X-Ray data was collected in Faculty of Arts and Sciences, Ondokuz Mayıs University, Turkey, by using Stoe IPDS II diffractometer and deposited with the CCDC number of 1515321.

References

1 Stoe&Cie. X-AREA (Version 1.18) and X-RED32 (Version1.04). Stoe&Cie, Darmstadt, Germany, 2002.Search in Google Scholar

2 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed

3 Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central

4 Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Cryst. 45 (2012) 849–854.10.1107/S0021889812029111Search in Google Scholar

5 Jadhav, S. A.; Kulkarni, K. M.; Patil, P. B.; Dhole, V. R.; Patil, S. S.: Design, synthesis and biological evaluation of some novel pyrazoline derivatives. Der Pharma Chemica 8 (2016) 38–45.Search in Google Scholar

6 Arias-Ruiz, S. N.; Romero, N.; Lobato-García, C. E.; Gómez-Rivera, A.; Mendoza, A.: Second monoclinic form of (E)-3-(4-fluorophenyl)-1-phenylprop-2-en-1-one. Acta Crystallogr. E69 (2013) o1694–o1695.10.1107/S1600536813028079Search in Google Scholar PubMed PubMed Central

7 Dimmock, J. R.; Elias, D. W.; Beazely, M. A.; Kandepu, N. M.: Bioactivities of chalcones. Curr. Med. Chem. 6 (1999) 1125–1149.10.2174/0929867306666220401182509Search in Google Scholar

8 Nowakowska, Z.: A review of anti-infective and anti-inflammatory chalcones. Eur. J. Med. Chem. 42 (2007) 125–137.10.1016/j.ejmech.2006.09.019Search in Google Scholar PubMed

9 Zhang, X.-W.; Zhao, D.-H.; Quan, Y.-C.; Sun, L.-P.; Yin, X.-M.; Guan, L.-P.: Synthesis and evaluation of antiinflammatory activity of substituted chalcone derivatives. Med. Chem. Res. 19 (2010) 403–412.10.1007/s00044-009-9202-zSearch in Google Scholar

10 Kouskoura, M.; Hadjipavlou-Litina, D.; Giakoumakou, M.: Synthesis and anti-inflammatory activity of chalcones and related mannich bases. Med.Chem. 4 (2008) 586–596.10.2174/157340608786242070Search in Google Scholar PubMed

11 Doan, T. N.; Tran, D. T.: Synthesis, antioxidant and antimicrobial activities of a novel series of chalcones, pyrazolic chalcones, and allylic chalcones. Pharmacol. Pharmacy 2 (2011) 282–288.10.4236/pp.2011.24036Search in Google Scholar

12 Pasquale, G.; Romanelli, G. P.; Autino, J. C.; García, J.; Ortiz, E. V.; Duchowicz, P. R.; Agric, J.: Quantitative structure-activity relationships of mosquito larvicidal chalcone derivatives. J. Agric. Food Chem. 60 (2012) 692–697.10.1021/jf203374rSearch in Google Scholar PubMed

13 Bhavana, P.; Sarveswari, S.; Weng Ng, S.; Tiekink, E. R. T.: Efficient ultrasound-assisted synthesis, spectroscopic, crystallographic and biological investigations of pyrazole-appended quinolinyl chalcones. J. Mol. Struct. 1081 (2015) 201–210.10.1016/j.molstruc.2014.10.026Search in Google Scholar

14 Ahn, S.; Lee, H. J.; Lim, Y.; Koh, D.: (E)-1-(3,5-Dimethoxyphenyl)-3-(3-methoxyphenyl)prop-2-en-1-one. Acta Crystallogr. E69 (2013) o666–o666.10.1107/S1600536813008982Search in Google Scholar PubMed PubMed Central

15 Ezhilarasi, K. S.; Jonathan, D. R.; Sathya, S.; Prathebha, K.; Usha, G.: (2E)-1-(3,5-Dihydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one. Acta Crystallogr. E70 (2014) o608–o609.10.1107/S1600536814009155Search in Google Scholar PubMed PubMed Central

Received: 2016-11-7
Accepted: 2017-4-5
Published Online: 2017-5-4
Published in Print: 2017-7-26

©2017 Yavuz Köysal et al., published by De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 25.5.2024 from https://www.degruyter.com/document/doi/10.1515/ncrs-2016-0357/html
Scroll to top button